Free Trial

Quoin Pharmaceuticals (QNRX) Institutional Ownership

$0.75
0.00 (0.00%)
(As of 05/22/2024 ET)

Institutional Ownership Changes (13F Filings) for Quoin Pharmaceuticals (NASDAQ:QNRX)

Current
Institutional Ownership
Percentage
8.63%
Number of
Institutional Buyers
(last 12 months)
1
Total
Institutional Inflows
(last 12 months)
$29.21K
Number of
Institutional Sellers
(last 12 months)
0
Get QNRX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Quoin Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Quoin Pharmaceuticals Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/20/2024 Virtu Financial LLC30,749$29K0.0%N/A0.773%
5/1/2023 Virtu Financial LLC147,907$70K0.0%N/A3.050%
11/7/2022 Virtu Financial LLC29,865$67K0.0%N/A2.948%
(Data available from 1/1/2016 forward)

QNRX Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of QNRX shares?

During the previous two years, the following institutional investors and hedge funds held shares of Quoin Pharmaceuticals shares: Virtu Financial LLC ($29K).Learn more on QNRX's institutional investors.

What percentage of Quoin Pharmaceuticals stock is owned by institutional investors?

8.63% of Quoin Pharmaceuticals stock is owned by institutional investors. Learn more on QNRX's institutional investor holdings.

Which institutional investors have been buying Quoin Pharmaceuticals stock?

The following institutional investors have purchased Quoin Pharmaceuticals stock in the last 24 months: Virtu Financial LLC ($208.52K).

How much institutional buying is happening at Quoin Pharmaceuticals?

Institutional investors have bought a total of 208,521 shares in the last 24 months. This purchase volume represents approximately $1.67M in transactions.


This page (NASDAQ:QNRX) was last updated on 5/23/2024 by MarketBeat.com Staff

From Our Partners